PubMed

Branched-chain Amino Acids and Pigment Epithelium-Derived Factor: Novel Therapeutic Agents for Hepatitis C Virus-associated Insulin Resistance.

Kawaguchi T, Yamagishi S, Sata M.

Curr Med Chem. 2009 Nov 17. [Epub ahead of print]PMID: 19929783 [PubMed - as supplied by publisher]

An alpha-glucosidase inhibitor, acarbose treatment decreases serum levels of glyceraldehyde-derived advanced glycation end products (AGEs) in patients with type 2 diabetes.

Tsunosue M, Mashiko N, Ohta Y, Matsuo Y, Ueda K, Ninomiya M, Tanaka SI, Hoshiko M, Yoshiyama Y, Takeuchi M, Ueda SI, Yamagishi SI.

Clin Exp Med. 2009 Oct 16. [Epub ahead of print] No abstract available. PMID: 19834782 [PubMed - as supplied by publisher]Related articles

Protective role of pigment epithelium-derived factor (PEDF) in early phase of experimental diabetic retinopathy.

Yoshida Y, Yamagishi S, Matsui T, Jinnouchi Y, Fukami K, Imaizumi T, Yamakawa R.

Diabetes Metab Res Rev. 2009 Oct;25(7):678-86.PMID: 19685553 [PubMed - in process]Related articles

Co-administration of ezetimibe enhances proteinuria-lowering effects of pitavastatin in chronic kidney disease patients partly via a cholesterol-independent manner.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Suzuki T, Ueda S, Fukami K, Okuda S, Yamagishi SI.

Pharmacol Res. 2009 Aug 8. [Epub ahead of print]PMID: 19666118 [PubMed - as supplied by publisher]Related articles

Regulation of advanced glycation end product (AGE)-receptor (RAGE) system by PPAR-gamma agonists and its implication in cardiovascular disease.

Yamagishi S, Nakamura K, Matsui T.

Pharmacol Res. 2009 Sep;60(3):174-8. Epub 2009 Jan 29. Review.PMID: 19646657 [PubMed - indexed for MEDLINE]Related articles

Decreased high-density lipoprotein cholesterol level is an independent correlate of circulating tumor necrosis factor-alpha in a general population.

Yamagishi S, Adachi H, Matsui T, Nakamura K, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Imaizumi T.

Clin Cardiol. 2009 Sep;32(9):E29-32.PMID: 19645041 [PubMed - in process]Related articles

Low-density lipoprotein levels are one of the independent determinants of circulating levels of advanced glycation end products in nondiabetic subjects.

Yamagishi S, Adachi H, Matsui T, Nakamura K, Takeuchi M, Enomoto M, Fukami A, Otsuka M, Kumagae S, Nanjo Y, Ueda S, Imaizumi T.

Clin Cardiol. 2009 Sep;32(9):E12-5.PMID: 19645034 [PubMed - in process]Related articles

Positive association of circulating levels of advanced glycation end products (AGEs) with pigment epithelium-derived factor (PEDF) in a general population.

Yamagishi SI, Matsui T, Adachi H, Takeuchi M.

Pharmacol Res. 2009 Jul 25. [Epub ahead of print]PMID: 19635565 [PubMed - as supplied by publisher]Related articles

Irbesartan inhibits advanced glycation end product (AGE)-induced proximal tubular cell injury in vitro by suppressing receptor for AGEs (RAGE) expression.

Matsui T, Yamagishi SI, Takeuchi M, Ueda S, Fukami K, Okuda S.

Pharmacol Res. 2009 Jul 25. [Epub ahead of print]PMID: 19635564 [PubMed - as supplied by publisher]Related articles

Reduction of postoperative abdominal adhesion and ileus by a bioresorbable membrane.

Fujii S, Shimada H, Ike H, Kunisaki C, Ohki S, Ichikawa Y, Ohta M, Yamagishi S, Osada S.

Hepatogastroenterology. 2009 May-Jun;56(91-92):725-8.PMID: 19621691 [PubMed - indexed for MEDLINE]Related articles

Surgical strategy for local recurrence after resection of rectal cancer.

Fujii S, Shimada H, Yamagishi S, Ota M, Ichikawa Y, Kunisaki C, Ike H, Ohki S.

Hepatogastroenterology. 2009 May-Jun;56(91-92):667-71.PMID: 19621677 [PubMed - indexed for MEDLINE]Related articles

Factors associated with serum high mobility group box 1 (HMGB1) levels in a general population.

Fukami A, Adachi H, Yamagishi S, Matsui T, Ueda S, Nakamura K, Enomoto M, Otsuka M, Kumagae S, Nanjo Y, Kumagai E, Esaki E, Murayama K, Hirai Y, Imaizumi T.

Metabolism. 2009 Dec;58(12):1688-93. Epub 2009 Jul 17.PMID: 19616266 [PubMed - in process]Related articles

Positive association of serum levels of advanced glycation end products and high mobility group box-1 with asymmetric dimethylarginine in nondiabetic chronic kidney disease patients.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Suzuki T, Yamada S, Takeuchi M, Fukami K, Ueda S, Adachi H, Matsui T, Okuda S, Yamagishi S.

Metabolism. 2009 Nov;58(11):1624-8. Epub 2009 Jul 15.PMID: 19604520 [PubMed - indexed for MEDLINE]Related articles

Up-regulation in receptor for advanced glycation end-products in inflammatory circumstances in bovine coccygeal intervertebral disc specimens in vitro.

Yoshida T, Park JS, Yokosuka K, Jimbo K, Yamada K, Sato K, Takeuchi M, Yamagishi S, Nagata K.

Spine (Phila Pa 1976). 2009 Jul 1;34(15):1544-8.PMID: 19564763 [PubMed - indexed for MEDLINE]Related articles

Allergic reactions to oxaliplatin in a single institute in Japan.

Ichikawa Y, Goto A, Hirokawa S, Kijima M, Ishikawa T, Chishima T, Suwa H, Yamamoto H, Yamagishi S, Osada S, Ota M, Fujii S.

Jpn J Clin Oncol. 2009 Sep;39(9):616-20. Epub 2009 Jun 25.PMID: 19556337 [PubMed - indexed for MEDLINE]Related articles

A Y-shaped vinyl hood that creates pneumoperitoneum in laparoscopic rectal cancer surgery (Y-hood method.): a new technique for laparoscopic low anterior resection.

Fujii S, Ota M, Yamagishi S, Kunisaki C, Osada S, Suwa H, Ichikawa Y, Shimada H.

Surg Endosc. 2009 Jun 11. [Epub ahead of print]PMID: 19517166 [PubMed - as supplied by publisher]Related articles

Evaluation of intraperitoneal lavage cytology before colorectal cancer resection.

Fujii S, Shimada H, Yamagishi S, Ota M, Kunisaki C, Ike H, Ichikawa Y.

Int J Colorectal Dis. 2009 Aug;24(8):907-14. Epub 2009 May 28.PMID: 19475411 [PubMed - indexed for MEDLINE]Related articles

Nifedipine, a calcium channel blocker, inhibits advanced glycation end product (AGE)-elicited mesangial cell damage by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gamma activation.

Matsui T, Yamagishi S, Takeuchi M, Ueda S, Fukami K, Okuda S.

Biochem Biophys Res Commun. 2009 Jul 24;385(2):269-72. Epub 2009 May 19.PMID: 19460355 [PubMed - indexed for MEDLINE]Related articles

Circulating levels of advanced glycation end products (AGE) and interleukin-6 (IL-6) are independent determinants of serum asymmetric dimethylarginine (ADMA) levels in patients with septic shock.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Suzuki T, Ueda Y, Yamada S, Shoji H, Takeuchi M, Ueda S, Matsui T, Adachi H, Okuda S, Yamagishi S.

Pharmacol Res. 2009 Dec;60(6):515-8. Epub 2009 May 18.PMID: 19450686 [PubMed - in process]Related articles

Ezetimibe decreases serum levels of asymmetric dimethylarginine (ADMA) and ameliorates renal injury in non-diabetic chronic kidney disease patients in a cholesterol-independent manner.

Nakamura T, Sato E, Fujiwara N, Kawagoe Y, Ueda Y, Suzuki T, Ueda S, Adachi H, Okuda S, Yamagishi S.

Pharmacol Res. 2009 Dec;60(6):525-8. Epub 2009 May 4.PMID: 19409491 [PubMed - in process]Related articles

Involvement of toxic AGEs (TAGE) in the pathogenesis of diabetic vascular complications and Alzheimer's disease.

Takeuchi M, Yamagishi S.

J Alzheimers Dis. 2009 Apr;16(4):845-58. Review.PMID: 19387117 [PubMed - indexed for MEDLINE]Related articles

Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD).

Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K, Okuda S.

Life Sci. 2009 Jun 5;84(23-24):853-6. Epub 2009 Apr 5.PMID: 19351540 [PubMed - indexed for MEDLINE]Related articles

Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older).

Nojiri K, Nagano Y, Tanaka K, Matsuo K, Yamagishi S, Ota M, Fujii S, Kunisaki C, Togo S, Shimada H.

Anticancer Res. 2009 Feb;29(2):583-8.PMID: 19331207 [PubMed - indexed for MEDLINE]Related articles

Atheroprotective properties of pigment epithelium-derived factor (PEDF) in cardiometabolic disorders.

Yamagishi S, Matsui T, Nakamura K.

Curr Pharm Des. 2009;15(9):1027-33. Review.PMID: 19275665 [PubMed - indexed for MEDLINE]Related articles

Clinical utility of acarbose, an alpha-glucosidase inhibitor in cardiometabolic disorders.

Yamagishi S, Matsui T, Ueda S, Fukami K, Okuda S.

Curr Drug Metab. 2009 Feb;10(2):159-63. Review.PMID: 19275550 [PubMed - indexed for MEDLINE]Related articles

Pigment epithelium-derived factor (PEDF) inhibits diabetes- or advanced glycation end product (AGE)-induced platelet CD40 ligand overexpression in rats.

Yamagishi SI, Matsui T, Ueda S, Takeuchi M.

Int J Cardiol. 2009 Feb 21. [Epub ahead of print]PMID: 19237211 [PubMed - as supplied by publisher]Related articles

Independent determinants of soluble form of receptor for advanced glycation end products in elderly hypertensive patients.

Nakamura K, Adachi H, Matsui T, Kurita Y, Takeuchi M, Yamagishi S.

Metabolism. 2009 Mar;58(3):421-5.PMID: 19217461 [PubMed - indexed for MEDLINE]Related articles

Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs).

Yamagishi S, Matsui T, Takenaka K, Nakamura K, Takeuchi M, Inoue H.

Diabetes Metab Res Rev. 2009 Mar;25(3):266-71.PMID: 19165765 [PubMed - indexed for MEDLINE]Related articles

Higher heart rate may predispose to obesity and diabetes mellitus: 20-year prospective study in a general population.

Shigetoh Y, Adachi H, Yamagishi S, Enomoto M, Fukami A, Otsuka M, Kumagae S, Furuki K, Nanjo Y, Imaizumi T.

Am J Hypertens. 2009 Feb;22(2):151-5. Epub 2008 Dec 11.PMID: 19151693 [PubMed - indexed for MEDLINE]Related articles

A case report: thoracic extramedullary hematopoiesis found by occurring spontaneous pneumothorax.

Kubokura H, Koizumi K, Yoshino N, Yamagishi S, Mikami I, Hirata T, Harada A, Kawamoto M, Shimizu K.

Ann Thorac Cardiovasc Surg. 2008 Dec;14(6):382-5.PMID: 19131925 [PubMed - indexed for MEDLINE]Related articlesFree article

Pigment epithelium-derived factor prevents melanoma growth via angiogenesis inhibition.

Abe R, Fujita Y, Yamagishi S, Shimizu H.

Curr Pharm Des. 2008;14(36):3802-9. Review.PMID: 19128233 [PubMed - indexed for MEDLINE]Related articles

Hyperglycemia induces oxidative and nitrosative stress and increases renal functional impairment in Nrf2-deficient mice.

Yoh K, Hirayama A, Ishizaki K, Yamada A, Takeuchi M, Yamagishi S, Morito N, Nakano T, Ojima M, Shimohata H, Itoh K, Takahashi S, Yamamoto M.

Genes Cells. 2008 Nov;13(11):1159-70.PMID: 19090810 [PubMed - indexed for MEDLINE]Related articles

Effects of high-AGE beverage on RAGE and VEGF expressions in the liver and kidneys.

Sato T, Wu X, Shimogaito N, Takino J, Yamagishi S, Takeuchi M.

Eur J Nutr. 2009 Feb;48(1):6-11. Epub 2008 Dec 12.PMID: 19083041 [PubMed - indexed for MEDLINE]Related articles

Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension.

Nakamura K, Yamagishi SI, Adachi H, Matsui T, Kurita Y, Imaizumi T.

Int J Cardiol. 2008 Dec 13. [Epub ahead of print]PMID: 19073347 [PubMed - as supplied by publisher]Related articles

Genetic ablation of FLRT3 reveals a novel morphogenetic function for the anterior visceral endoderm in suppressing mesoderm differentiation.

Egea J, Erlacher C, Montanez E, Burtscher I, Yamagishi S, Hess M, Hampel F, Sanchez R, Rodriguez-Manzaneque MT, Bösl MR, Fässler R, Lickert H, Klein R.

Genes Dev. 2008 Dec 1;22(23):3349-62.PMID: 19056886 [PubMed - indexed for MEDLINE]Related articlesFree article

Pigment epithelium-derived factor (PEDF) inhibits collagen-induced platelet activation by reducing intraplatelet nitrotyrosine levels.

Yamagishi SI, Matsui T, Nakamura K, Takenaka K.

Int J Cardiol. 2008 Nov 28. [Epub ahead of print]PMID: 19046781 [PubMed - as supplied by publisher]Related articles

Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.

Fujimura T, Yamagishi S, Ueda S, Fukami K, Shibata R, Matsumoto Y, Kaida Y, Hayashida A, Koike K, Matsui T, Nakamura K, Okuda S.

Nephrol Dial Transplant. 2009 May;24(5):1397-406. Epub 2008 Nov 28.PMID: 19042927 [PubMed - indexed for MEDLINE]Related articles

Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.

Shibata R, Ueda S, Yamagishi S, Kaida Y, Matsumoto Y, Fukami K, Hayashida A, Matsuoka H, Kato S, Kimoto M, Okuda S.

Nephrol Dial Transplant. 2009 Apr;24(4):1162-9. Epub 2008 Nov 17.PMID: 19015171 [PubMed - indexed for MEDLINE]Related articles

Role of asymmetric dimethylarginine (ADMA) in diabetic vascular complications.

Yamagishi S, Ueda S, Nakamura K, Matsui T, Okuda S.

Curr Pharm Des. 2008;14(25):2613-8. Review.PMID: 18991678 [PubMed - indexed for MEDLINE]Related articles

Pigment epithelium-derived factor (PEDF): its potential therapeutic implication in diabetic vascular complications.

Yamagishi S, Matsui T, Nakamura K, Ueda S, Noda Y, Imaizumi T.

Curr Drug Targets. 2008 Nov;9(11):1025-9. Review.PMID: 18991613 [PubMed - indexed for MEDLINE]Related articles

Telmisartan inhibits advanced glycation end products (AGEs)-elicited endothelial cell injury by suppressing AGE receptor (RAGE) expression via peroxisome proliferator-activated receptor-gammaactivation.

Yamagishi S, Matsui T, Nakamura K, Takeuchi M, Inoue H.

Protein Pept Lett. 2008;15(8):850-3.PMID: 18855759 [PubMed - indexed for MEDLINE]Related articles

Preoperative serum carcinoembryonic antigen level as a predictive factor of recurrence after curative resection of colorectal cancer.

Takagawa R, Fujii S, Ohta M, Nagano Y, Kunisaki C, Yamagishi S, Osada S, Ichikawa Y, Shimada H.

Ann Surg Oncol. 2008 Dec;15(12):3433-9. Epub 2008 Oct 10.PMID: 18846401 [PubMed - indexed for MEDLINE]Related articles

Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats.

Yamagishi S, Matsui T, Nakamura K, Takenaka K.

Clin Exp Med. 2009 Mar;9(1):73-6. Epub 2008 Sep 25.PMID: 18815870 [PubMed - indexed for MEDLINE]Related articles

Possible molecular mechanisms by which angiotensin II type 1 receptor blockers (ARBs) prevent the development of atrial fibrillation in insulin resistant patients.

Yamagishi SI, Matsui T, Nakamura K.

Horm Metab Res. 2008 Sep;40(9):640-4. Epub 2008 Sep 15. Review.PMID: 18792876 [PubMed - indexed for MEDLINE]Related articles

Pigment epithelium-derived factor (PEDF) ameliorates advanced glycation end product (AGE)-induced hepatic insulin resistance in vitro by suppressing Rac-1 activation.

Yoshida T, Yamagishi S, Nakamura K, Matsui T, Imaizumi T, Takeuchi M, Koga H, Ueno T, Sata M.

Horm Metab Res. 2008 Sep;40(9):620-5. Epub 2008 Sep 15.PMID: 18792873 [PubMed - indexed for MEDLINE]Related articles

Glyceraldehyde-derived advanced glycation end products (AGEs). A novel biomarker of postprandial hyperglycaemia in diabetic rats.

Kitahara Y, Takeuchi M, Miura K, Mine T, Matsui T, Yamagishi S.

Clin Exp Med. 2008 Sep;8(3):175-7. Epub 2008 Sep 13.PMID: 18791692 [PubMed - indexed for MEDLINE]Related articles

[Endothelial injury and CKD]

Ueda S, Matsumoto Y, Kaida Y, Okuda S, Yamagishi S.

Nippon Rinsho. 2008 Sep;66(9):1634-8. Review. Japanese. No abstract available. PMID: 18788387 [PubMed - indexed for MEDLINE]Related articles

Possible link of food-derived advanced glycation end products (AGEs) to the development of diabetes.

Yamagishi S, Matsui T, Nakamura K.

Med Hypotheses. 2008 Dec;71(6):876-8. Epub 2008 Sep 9.PMID: 18783891 [PubMed - indexed for MEDLINE]Related articles

Blockade of the advanced glycation end products (AGEs) and their receptor (RAGE) system is a possible mechanism for sustained beneficial effects of multifactorial intervention on mortality in type 2 diabetes.

Yamagishi S, Matsui T, Nakamura K.

Med Hypotheses. 2008 Nov;71(5):749-51. Epub 2008 Aug 16.PMID: 18710793 [PubMed - indexed for MEDLINE]Related articles

Circulating matrix metalloproteinase-2 is an independent correlate of proteinuria in patients with chronic kidney disease.

Nagano M, Fukami K, Yamagishi S, Ueda S, Kaida Y, Matsumoto T, Yoshimura J, Hazama T, Takamiya Y, Kusumoto T, Gohara S, Tanaka H, Adachi H, Okuda S.

Am J Nephrol. 2009;29(2):109-15. Epub 2008 Aug 14.PMID: 18701818 [PubMed - indexed for MEDLINE]Related articles